宇直泰貿易股份有限公司

主成分
Methyldopa contains not less than 98.5% and not more than 101.0% of C10H13NO4‧3/2H2O calculated on anhydrous basis. 
適應症
降血壓藥
主成分
Primidone contains not less than 98.0% and not more than 102.0% of C12H14N2O2 calculated on the dried basis. 
適應症
抗痙攣藥
主成分
Cetirizine Dihydrochloride contains not less than 99.0% and not more than 100.5% of C21H27Cl3N2O3 calculated on dried basis. 
適應症
抗組織胺劑。
主成分
Oxybutynin Hydrochloride contains not less than 99.0% and not more than 102.0% of C22H31NO3‧HCl, calculated on the dried basis. 
適應症
副交感神經抑制藥
主成分
Dextromethorphan HBr. contains not less than 98.0% and not more than 102.0% of C18H25NO, HBr, H2O calculated on anhydrous basis. 
適應症
鎮咳藥
主成分
Alverine Citrate contains not less than 99.0% and not more than 101.0% of C26H35NO7 calculated on dried substance. 
適應症
平滑肌弛緩劑
主成分
Metformin HCl contains not less than 98.5% and not more than 101.0% of C4H12ClN5 calculated with reference to the dried substance. 
適應症
降血糖劑。
主成分
Gemfibrozil contains not less than 98.0% and not more than 102.0% of C15H22O3 calculated on the anhydrous basis. 
適應症
降血脂劑。
主成分
,,Diosmectite (Dioctahedral smectite) contains not less than 12.0% and not more than 25.0% of Al2O3 and not less than 55.0% and not more than 65.0% of SiO2, calculated on the anhydrous basis. 
適應症
急性和慢性腹瀉治療
主成分
Flupentixol Dihydrochloride contains not less than 98.0% and not more than 101.5% of C23H25F3N2OS‧2HCl, calculated on the anhydrous basis. 
適應症
寧神藥
主成分
Solifenacin Succinate contains not less than 99.0% and not more than 101.0% of C27H32N2O6, calculated on the dried basis. 
適應症
膀胱過動症
主成分
Olmesartan Medoxomil contains not less than 97.5% and not more than 102.0% of C29H30N6O6, calculated on the anhydrous substance. 
適應症
高血壓用藥
主成分
Simvastatin contains not less than 98.0 % and not more than 101.0 % of C25H38O5, calculated on the anhydrous basis. 
適應症
降血脂劑
主成分
Pitavastatin Calcium contains 98.0% ~ 102.0% of C50H46F2N2O8Ca calculated on anhydrous basis. 
適應症
血脂調節劑。
主成分
Telmisartan contains not less than 99.0% and not more than 101.0% of C33H30N4O2 calculated on dried substance. 
適應症
降血壓藥
主成分
Amlodipine Besilate contains not less than 97.0% and not more than 102.0% of C20H25ClN2O5‧C6H5SO3H calculated on the dried basis. 
適應症
心臟血管用藥
主成分
Febuxostat contains not less than 98.0% and not more than 102.0% of C16H16N2O3S, calculated on the anhydrous basis. 
適應症
高尿酸血症用藥
主成分
Enalapril Maleate contains not less than 98.0% and not more than 102.0% of C20H28N2O5‧C4H4O4 calculated on the dried basis. 
適應症
降血壓劑。
主成分
Tenofovir Disoproxil Fumarate contains not less than 97.0% and not more than 101.0% of C23H34N5O14P, calculated on the anhydrous basis 
適應症
抗病毒藥
主成分
Tolterodine Tartrate contains not less than 97.0% and not more than 103.0% of C26H37NO7 
適應症
治療尿失禁
主成分
Betahistine Mesylate (e.q. Betahistine Dimesilate) contains not less than 98.0% and not more than 101.0% of C10H20N2O6S2, calculated on the anhydrous substance. 
適應症
治療梅尼艾氏症候群所引起之眩暈、聽力障礙。
主成分
Rizatriptan Benzoate contains not less than 98.0% and not more than 102.0% of C22H25N5O2, calculated on the anhydrous substance. 
適應症
偏頭痛用藥
主成分
Midodrine Hydrochloride contains not less than 98.0% and not more than 102.0% of C12H18N2O4‧HCl, calculated on the anhydrous basis. 
適應症
降血壓藥
主成分
Calcium Folinate (Leucovorin Calcium) contains not less than 97.0% and not more than 102.0% of C20H21CaN7O7, calculated on the anhydrous substance. 
適應症
抗葉酸拮抗藥
主成分
Losartan Potassium contains not less than 98.5% and not more than 101.0% of C22H22CIKN6O calculated on the anhydrous, solvent-free basis 
適應症
降血壓劑。
主成分
Amiodarone Hydrochloride contains not less than 98.5% and not more than 101.0% of C25H29I2NO3‧HCl, calculated on the dried substance. 
適應症
不整脈治療劑
主成分
Pioglitazone Hydrochloride contains not less than 98.0% and not more than 102.0% of C19H20N2O3S‧HCl, calculated on the anhydrous basis. 
適應症
糖尿病用藥。
主成分
BENPROPERINE PHOSPHATE CONTAINS NOT LESS THAN 98.5% OF C21H27F3NO.H3PO4 CALCULATED ON THE DRIED BASIS. 
適應症
鎮咳。
主成分
Aceclofenac contains 99.0~101.0% of C6H13Cl2NO4 calculated on the dried substance. 
適應症
治療骨關節炎、類風濕性關節。
主成分
Hyoscyamine Sulfate contains not less than 98.5% and not more than 100.5% of (C17H23NO3)2‧H2SO4‧2H2O, calculated on the anhydrous basis. 
適應症
副交感神經抑制劑
主成分
Miglitol contains not less than 98.5% of C8H17NO5, calculated on the anhydrous basis. 
適應症
第二型糖尿病
主成分
Amorolfine HCl contains not less than 99.0% and not more than 101.0% of C21H36ClNO, calculated on the dried substance. 
適應症
抗黴菌劑
主成分
Entecavir Monohydrate contains not less than 98.0% and not more than 102.0% of C12H15N5O3‧H2O calculated on the anhydrous basis.  
適應症
抗病毒用藥。
主成分
Azithromycin contains not less than 96.0% and not more than102.0% of C38H72N2O12‧xH2O calculated on the anhydrous substance. 
適應症
革蘭氏陽性、陰性及厭氧菌引起之下呼吸道感染、皮膚及軟組織感染、中耳炎、上呼吸道感染和性傳染病。
主成分
Ramelteon contains not less than 98.0% and not more than 102.0% of C16H21NO2, calculated on the anhydrous basis. 
適應症
精神抑制藥
主成分
Prilocaine contains not less than 98.0% and not more than 102.0% of C13H20N2O, calculated on the anhydrous basis. 
適應症
局部麻醉劑
主成分
Eprazinone HCl contains not less than 98.5% of C24H32N2O2∙2HCl calculated on dried substance. 
適應症
鎮咳及袪痰劑
主成分
Fluvastatin Sodium contains not less than 98.0% and not more than 102.0% of C24H25FNNaO4, calculated on the anhydrous basis. 
適應症
降血脂劑
主成分
Orlistat contains not less than 98.0% and not more than 101.5.0% of C29H53NO5 calculated on the anhydrous substance. 
適應症
抗肥胖劑。
主成分
Paliperidone contains not less than 98.0% and not more than 102.0% of C23H27FN4O3, calculated on the anhydrous basis. 
適應症
思覺失調症、情感思覺失調症
主成分
Cefoperazone Sodium and Sulbactam Sodium (1:1) contains cefoperazone (C25H27N9O8S2) not less than 435μg and sulbactam (C8H11NO5S) not less than 445μg, and the content ratio of cefoperazone to sulbactam is (0.9~1.1):1 calculated on the anhydrous basis. 
適應症
抗生素
主成分
Amlodipine Besylate contains not less than 97.0% and not more than 102.0% of C20H25ClN2O5˙C6H6O3S, calculated on the anhydrous basis. 
適應症
心臟血管用藥
主成分
Esculin (e. q. Esculoside) contains 98%~100.5% of C15H16O9, 1.5 H2O (dried basis.) 
適應症
痔瘡、肛門周圍炎、肛門龜裂。
主成分
Levetiracetam contains NLT 98.0% and NMT 102.0% of C8H14N2O2, calculated on the anhydrous and solvent-free basis. 
適應症
抗癲癇藥
主成分
Tramadol Hydrochloride contains not less than 99.0% and not more than 101.0% of C16H26ClNO2, calculated on the anhydrous substance. 
適應症
鎮痛劑
主成分
Sennosides contains not less than 90.0% and not more than 110.0% of C42H36O20Ca, calculated on the anhydrous basis. 
適應症
瀉藥
主成分
Etoricoxib contains not less than 98.0 % and not more than 102.0 % of C18H15ClN2O2S, calculated on the anhydrous basis. 
適應症
消炎止痛
主成分
Tadalafil contains not less than 97.5% and not more than 102.0% of C22H19N3O4, calculated on the anhydrous basis. 
適應症
治療勃起功能障礙
主成分
Imatinib Mesylate(imatinib mesilate) contains not less than 98.0% and not more than 102.0% of C30H35N7SO4, calculated on the anhydrous basis. 
適應症
白血病用藥
主成分
Calcium Acetate contains not less than 99.0% and not more than 100.5% of C4H6CaO4, calculated on the anhydrous basis. 
適應症
腎衰竭末期之高磷酸鹽血症用藥
主成分
Ciprofloxacin Hydrochloride contains not less than 98.0% and not more than 102.0% of C17H18FN3O3, HCl, calculated on the anhydrous basis. 
適應症
抗菌藥
主成分
Dapagliflozin Propanediol contains not less than 98.0% and not more than 102.0% of C24H33ClO8, calculated on the anhydrous basis. 
適應症
降血糖用藥
主成分
Sitagliptin Phosphate Monohydrate contains not less than 98.0% and not more than 102.0% of C16H18F6M5O5P, calculated on the anhydrous substance. 
適應症
降血糖藥
主成分
Metformin hydrochloride contains not less than 98.5% and not more than 101.0% of C4H12ClN5, calculated on the dried substance. 
適應症
糖尿病治療藥
主成分
penciclovir contains not less than 99.0% and not more than 101.0% of C10H15N5O3, calculated on dried substance. 
適應症
治療由單純皰疹病毒引起之後發性唇皰疹
主成分
Buclizine Hydrochloride contains not less than 99.0 % and not more than 100.5 % of C28H33ClN2‧2HCl, calculated on the anhydrous basis. 
適應症
抗組織胺劑
主成分
Gabapentin contains not less than 98.0% and not more than 102.0% of C9H17NO2, calculated on the anhydrous basis. 
適應症
抗痙攣藥
主成分
Lovastatin contains not less than 98.5 and more than 101.0% of C24H36O5, calculated on the dried basis. 
適應症
血脂調節劑。
主成分
Simvastatin contains not less than 98.0% and not more than 101.0% of C25H38O5 calculated on dry basis. 
適應症
血脂調節劑。
主成分
Melatonin contains not less than 98.5% and not more than 101.5% of C13H16N2O2, calculated on the dried basis. 
適應症
失眠治療
主成分
Isotretinoin contains not less than 98.0% and not more than 102.0% of C20H28O2, calculated on the anhydrous basis. 
適應症
角質溶解藥
主成分
Meclizine Hydrochloride contains not less than 97.0% and not more than 100.5% of C25H29Cl3N2, calculated on the anhydrous basis. 
適應症
抗噁心藥
主成分
Acarbose contains not less than 95.0% and not more than the equivalent of 102.0% C25H43NO18, calculated on the anhydrous basis. 
適應症
糖尿病治療劑。
主成分
Febuxostat (Form-A) contains not less than 98.0% and not more than 102.0% of C16H16N2O3S, calculated on the dried basis. 
適應症
高尿酸血症用藥
主成分
Efavirenz contains not less than 98.0% and not more than 102.0% of C14H9ClF3NO2, calculated on the anhydrous, solvent-free basis. 
適應症
抗病毒藥物
主成分
Pravastatin Sodium contains not less than 97.0% and not more than 102.0% of C23H35NaO7 calculated on anhydrous and ethanol-free substance. 
適應症
降血脂劑。
主成分
Docusate sodium contains not less than 98.0% and not more than 101.0% of C20H37NaO7S, calculated on the anhydrous substance.  
適應症
通便藥
主成分
Brotizolam contains not less than 99.0% and not more than 101.0% of C15H10BrClN4S, calculated on the anhydrous basis. 
適應症
失眠症的治療
主成分
Ezetimibe contains not less than 98.0% and not more than 102.0% of C24H21F2NO3, calculated on the anhydrous basis. 
適應症
降血脂藥
主成分
 
適應症
抗腫瘤藥
主成分
Amlodipine Besylate contains not less than 97.0% and not more than 102.0% of C20H25ClN2O5・C6H6O3S, calculated on anhydrous basis. 
適應症
治療高血壓,鈣離子拮抗劑
主成分
Diosmin contains not less than 90.0% and not more than 102.0% of C28H32O15, calculated on the anhydrous substance. 
適應症
協助改善慢性靜脈功能不全引起之局部腫脹或疼痛、痔瘡症狀之緩解
主成分
Ivermectin contains not less than 95.0% and not more than 102.0% of C48H74O14 + C47H72O14(H2B1a+H2B1b), calculated on the anhydrous substance. 
適應症
驅蟲劑
主成分
Mirabegron contains not less than 98.0% and not more than 102.0% of C21H24N4O2S, calculated on the anhydrous basis. 
適應症
β3-腎上腺接受體作用劑
主成分
Sodium Azulene Sulfonate (Azulene Water Soluble) contains not less than 98.5% and not more than 101.5% of C15H17NaO3S.1/2H2O, calculated on the drying. 
適應症
急慢性胃炎、胃潰瘍
主成分
Clopidogrel Bisulfate contains not less than 97.0% and not more than 101.5% of C16H16ClNO2S‧H2SO4, calculated on the dried basis. 
適應症
抗凝血劑
主成分
Febuxostat (Form A) contains not less than 98.0% and not more than 102.0% of C16H16N2O3S, calculated on the anhydrous basis. 
適應症
高尿酸血症用藥
主成分
Imatinib Mesylate contains not less than 98.0% and not more than 102.0% of C30H35N7SO4, calculated on the anhydrous basis. 
適應症
白血病用藥
主成分
Lacidipine contains not less than 97.5% and not more than 102.0% of C26H33NO6, calculated on the anhydrous basis. 
適應症
高血壓
主成分
Levocetirizine Dihydrochloride contains not less than 98.0 % and not more than 102.0 % of C21H25ClN2O3‧2HCl, calculated on the dried basis. 
適應症
抗過敏製劑
主成分
Meropenem contains not less than 75.0% and not more than 85.0% of C17H25N3O5S calculated on the dried basis. 
適應症
抗菌劑。
主成分
Bupropion hydrochloride contains not less than 98.0% and not more than 102.0% of C13H18ClNO.HCl, calculated on the anhydrous basis. 
適應症
抗憂鬱藥
主成分
Atorvastatin calcium (Form I) contains not less than 98.0% and not more than 101.0% of C66H68CaF2N4O10‧3H2O, on the anhydrous and solvent-free basis. 
適應症
高膽固醇血症、高三酸甘油脂血症。
主成分
Lenalidomide contains not less than 98.0% and not more than 102.0% of C13H13N3O3, calculated on the anhydrous basis. 
適應症
抗癌藥原料藥
主成分
Rasagiline Mesylate contains not less than 98.0% and not more than 102.0% of C13H17NO3S, calculated on the anhydrous basis. 
適應症
帕金森氏症用藥
主成分
Dipyridamole contains not less than 98.5% and not more than 101.5% of C24H40N8O4, calculated on the anhydrous basis. 
適應症
血小板集結降低藥
主成分
Zolpidem tartrate (eq. zolpidem hemitartrate) contains not less than 98.5% and not more than 101.0% of C42H48N6O8, calculated on the anhydrous substance. 
適應症
安眠藥
主成分
Etodolac contains not less than 98.0% and not more than 102.0% of C17H21NO3, calculated on the anhydrous substance. 
適應症
消炎鎮痛藥
主成分
TERAZOSIN (HCL 2H2O) 
適應症
降壓劑。
主成分
ZOLPIDEM HEMITARTRATE 
適應症
鎮靜劑。
主成分
Alfuzosin Hydrochloride contains not less than 98.5% and not more than 101.0% of C19H28ClN5O4 calculated on an anhydrous basis. 
適應症
良性前列腺肥大。
主成分
Fluvoxamine Maleate contains not less than 99.0% and not more than 101.0% of C19H25F3N2O6 calculated on the dried basis 
適應症
抗精神憂鬱藥
主成分
Bambuterol HCl contains not less than 98.5% and not more than 101.5% of C18H29N3O5。HCl calculated on anhydrous basis. 
適應症
支氣管擴張劑。
主成分
 
適應症
惡性腫瘤之蝕骨性骨頭轉移,惡性高血鈣症。
主成分
Carvedilol contains 99.0%~101.0% of C24H26N2O4 calculate on the dried substance. 
適應症
高血壓,鬱血性心臟衰竭
主成分
Amphotericin B has a potency of not less than 750IU of C47H73NO17 per mg, calculated on the dried basis. 
適應症
抗生素
主成分
Valsartan contains not less than 98.0% and not more than 102.0% of C24H29N5O3 calculated on the anhydrous basis. 
適應症
降血壓劑。
主成分
Fosinopril Sodium contains not less than 98.0% and not more than 102.0% of C30H45NNaO7P calculated on anhydrous basis. 
適應症
高血壓、心衰竭。
主成分
Sennosides contains not less than 90.0% and not more than 110.0% of the labeled amount of sennosides. The labeled amount is not less than 60.0%, calculated on the dried basis. 
適應症
緩瀉劑。
主成分
Azulene Water Soluble contains not less than 98.5% and not more than 101.5% of C15H17NaO3S.1/2H2O. 
適應症
急慢性胃炎、胃潰瘍。
主成分
Lansoprazole contains not less than 99.0% and not more than 101.0% of C16H14F3N3O2S calculated on an anhydrous basis.\n 
適應症
消化性潰瘍。
主成分
Benzydamine HCl contains not less than 99.0% and not more than 101.0% of C19H23N3O, HCl calculated with reference to the dried substance. 
適應症
消炎、鎮痛。
主成分
Lamivudine contains not less than 98.0% and not more than 102.0% of C8H11N3O3S, calculated on the anhydrous and solvent-free basis. 
適應症
抗病毒藥。
主成分
SIMVASTATIN 
適應症
血脂調節劑。
主成分
Citalopram Hydrobromide contains not less than 99.0% and not more than 101.5% of C20H21FN2O.HBR calculated on the anhydrous basis. 
適應症
抗憂鬱劑。
主成分
Sertraline Hydrochloride contains not less than 98.0% and not more than 102.0% of C17H17Cl2N.HCl calculated on dried basis. 
適應症
抗憂鬱劑。
主成分
Clopidogrel Hydrogen Sulphate contains not less than 97.0% and not more than 101.5% of C16H16ClNO2S.H2SO4 calculated on dried basis. 
適應症
降低近期發生中風、心肌梗塞或週邊動脈血管疾病的粥狀動脈硬化病人之粥狀動脈硬化事件的發生。
主成分
Quetiapine Fumarate contains not less than 98.0% and not more than 102.0% of (C21H25N3O2S)2.C4O4H4 calculated on the dried basis. 
適應症
思覺失調症、雙極性疾患之躁症發作。
主成分
Levocetirizine Dihydrochloride contains not less than 98.0% and not more than 102.0% of C21H25ClN2O3.2HCl calculated on the dried basis. 
適應症
抗過敏製劑
主成分
PROCATEROL HYDROCHLORIDE HEMIHYDRATE 
適應症
支氣管擴張劑。
主成分
Amlodipine Besylate contains not less than 97.0% and not more than 102% of C20H25ClN2O5.C6H5SO3H calculated on the dried basis. 
適應症
心臟血管用藥。
主成分
Assay by HPLC: Terbinafine Hydrochloride contains not less than 98.0% and not more than 102.0% of C21H25N.HCl calculated on dried basis. 
適應症
抗黴菌劑。
主成分
Losartan Potassium contains not less than 98.5% and not more than 101.0% of C22H22ClKN6O calculated on anhydrous basis. 
適應症
降血壓劑。
主成分
Calcium Folinate contains not less than 97.0% and not more than the equivalent of 102.0% of calcium (2S)-2-{[4-[[[(6RS)-2-amino-5-formy-4-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl]amino]benzoyl]amino} pentanedioate and not less than 7.54 percent and not more than the equivalent of 8.14 percent of Ca, both calculated with reference to the anhydrous and solvent-free substance. 
適應症
葉酸拮抗劑使用過量之解毒劑。
主成分
Assay:Methylprednisolone Sodium Succinate sterile buffered contains not less than 97.0% and not more than 103.0% of C26H33NaO8 calculated phosphates free, dried substance. 
適應症
副腎皮質荷爾蒙劑。
主成分
Escitalopram Oxalate contains not less than 98.0% and not more than 101.0% of C20H21FN2O‧C2H2O4 calculated on the dried basis. 
適應症
憂鬱症之治療及預防復發。
主成分
TOPIRAMATE 
適應症
抗癲癇藥。
主成分
Ketorolac Tromethamine contains not less than 98.5% and not more than 101.5% of C15H13NO3‧C4H11NO3, calculated on the dried basis. 
適應症
鎮痛、消炎藥。
主成分
Perindopril tert-Butylamine (Perindopril Erbumine) contains not less than 99.0% and not more than 101.0% of C19H32N2O5‧C4H11N calculated on anhydrous substance. 
適應症
降血壓劑。
主成分
Thalidomide contains not less than 98.0% and not more than 101.5% of C13H10N2O4 calculated on the anhydrous basis. 
適應症
抗癌藥原料藥
主成分
Pravastatin sodium contains not less than 97.0% and not more than 102.0% of C23H35NaO7, calculated on the anhydrous basis. 
適應症
血脂調節劑
主成分
Mosapride Citrate Dihydrate contains not less than 98.0% and not more than the equivalent of 101.5% C21H25ClFN3O3, C6H8O7, 2H2O calculated on anhydrous basis. 
適應症
胃腸蠕動增進劑。
主成分
FUSIDIC ACID 
適應症
抗菌劑
主成分
ADAPALENE 
適應症
維生素A類化合物
主成分
Fenofibrate contains not less than 98.5% and not more than the equivalent of 101.0% of C20H21ClO4 calculated with reference to the dried substance. 
適應症
高脂質血症。
主成分
FUSIDATE SODIUM 
適應症
抗菌劑
主成分
Pantoprazole Sodium contains not less than 98.0% and not more than 102% of C16H14F2N3NaO4S, calculated on anhydrous basis. 
適應症
潰瘍治療藥。
主成分
Etoricoxib contains not less than 98.0% and not more than 102% of C18H15ClN2O2S, calculated on anhydrous basis. 
適應症
消炎止痛
主成分
Simeticone is a mixture of silicon dioxide and poly(dimethylsiloxane). The content of silica and poly(dimethylsiloxane) is 4%-7% and 90.5%-99.0%, respectively. 
適應症
消泡劑、製劑輔助劑
主成分
Montelukast Sodium contains not less than 98.0% and not more than 102.0% of C35H35ClNNaO3S, calculated on the anhydrous basis. 
適應症
氣喘用藥
主成分
 
適應症
β3-腎上腺接受體作用劑。
主成分
Melitracen Hydrochloride contains not less than 98.0% and not more than 101.0% of C21H25N‧HCl, calculated on the anhydrous basis. 
適應症
抗憂鬱劑
主成分
Irbesartan contains not less than 98.0% and not more than 102.0% of C25H28N6O, calculated on the anhydrous basis.  
適應症
降血壓劑。
主成分
Zaleplon contains not less than 98.0% and not more than 102.0% of C17H15N5O, calculated on the anhydrous basis. 
適應症
抗失眠用藥
主成分
Eszopiclone contains not less than 99.0% and not more than 100.5% of C17H17ClN6O3 calculated on the dried basis. 
適應症
失眠症